Methods and products related to the analysis of polysaccarides

Details Methods and products related to the analysis of polysaccarides Methods and products related to the analysis of polysaccarides

2006-08-01

2006-08-01

Gitomer, Ralph (Department: 1651)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving blood clotting factor

C436S069000

Reexamination Certificate

active

07083937

ABSTRACT:
The invention relates to methods and products for characterizing and using polysaccharides. Low molecular weight heparin products and methods of use are described. Methods for characterizing purity and activity of polysaccharide preparations including glycosaminoglycans such as heparin are also described.

REFERENCES:
patent: 4281108 (1981-07-01), Fussi
patent: 4341869 (1982-07-01), Langer, Jr. et al.
patent: 4373023 (1983-02-01), Langer et al.
patent: 4396762 (1983-08-01), Langer et al.
patent: 4443545 (1984-04-01), Langer, Jr. et al.
patent: 4551296 (1985-11-01), Kavesh et al.
patent: 4679555 (1987-07-01), Sackner
patent: 4745105 (1988-05-01), Griffin et al.
patent: 4757056 (1988-07-01), Van Gorp et al.
patent: 4830013 (1989-05-01), Maxwell
patent: 4928694 (1990-05-01), Maxwell
patent: 4942156 (1990-07-01), Foley et al.
patent: 4990502 (1991-02-01), Lormeau et al.
patent: 5010063 (1991-04-01), Piani et al.
patent: 5039529 (1991-08-01), Bergendal et al.
patent: 5106734 (1992-04-01), Nielsen
patent: 5152784 (1992-10-01), Tsilibary
patent: 5164378 (1992-11-01), Conti et al.
patent: 5169772 (1992-12-01), Zimmerman et al.
patent: 5204323 (1993-04-01), Findlay et al.
patent: 5252339 (1993-10-01), Cristofori et al.
patent: 5262325 (1993-11-01), Zimmermann et al.
patent: 5290695 (1994-03-01), Morikawa et al.
patent: 5338677 (1994-08-01), Zimmermann et al.
patent: 5389539 (1995-02-01), Sasisekharan et al.
patent: 5453171 (1995-09-01), Ma et al.
patent: 5474987 (1995-12-01), Cohen et al.
patent: 5567417 (1996-10-01), Sasisekharan et al.
patent: 5569366 (1996-10-01), Chen et al.
patent: 5569600 (1996-10-01), Sasisekharan et al.
patent: 5576304 (1996-11-01), Kakkar et al.
patent: 5599801 (1997-02-01), Branellec et al.
patent: 5607859 (1997-03-01), Biemann et al.
patent: 5618917 (1997-04-01), Toback et al.
patent: 5619421 (1997-04-01), Venkataraman et al.
patent: 5681733 (1997-10-01), Su et al.
patent: 5687090 (1997-11-01), Chen et al.
patent: 5714376 (1998-02-01), Sasisekharan et al.
patent: 5744515 (1998-04-01), Clapper
patent: 5752019 (1998-05-01), Rigoutsos et al.
patent: 5753445 (1998-05-01), Fillit et al.
patent: 5759767 (1998-06-01), Lakowicz et al.
patent: 5763427 (1998-06-01), Weitz et al.
patent: 5776434 (1998-07-01), Purewal et al.
patent: 5795875 (1998-08-01), Holme et al.
patent: 5808021 (1998-09-01), Holme et al.
patent: 5824299 (1998-10-01), Luster et al.
patent: 5830726 (1998-11-01), Sasisekharan et al.
patent: 5855913 (1999-01-01), Hanes et al.
patent: 5856928 (1999-01-01), Yan
patent: 5874064 (1999-02-01), Edwards et al.
patent: 5879713 (1999-03-01), Roth et al.
patent: 5919693 (1999-07-01), Su et al.
patent: 5922358 (1999-07-01), Doutremepuich et al.
patent: 5952653 (1999-09-01), Covey et al.
patent: 5968822 (1999-10-01), Pecker et al.
patent: 5985309 (1999-11-01), Edwards et al.
patent: 5997863 (1999-12-01), Zimmermann et al.
patent: 6013628 (2000-01-01), Skubitz et al.
patent: 6116237 (2000-09-01), Schultz et al.
patent: 6136295 (2000-10-01), Edwards et al.
patent: RE37053 (2001-02-01), Hanes et al.
patent: 6190875 (2001-02-01), Ben-Artzi et al.
patent: 6217863 (2001-04-01), Godavarti et al.
patent: 6268146 (2001-07-01), Shultz et al.
patent: 6291439 (2001-09-01), Klock
patent: 6309853 (2001-10-01), Friedman et al.
patent: 6333051 (2001-12-01), Kabanov et al.
patent: 6597996 (2003-07-01), Venkataraman et al.
patent: 0244236 (1987-11-01), None
patent: 0 342 215 (1989-11-01), None
patent: 0394971 (1990-10-01), None
patent: 0 433 225 (1991-06-01), None
patent: 0 557 887 (1993-09-01), None
patent: WO 92/01003 (1992-01-01), None
patent: WO 93/05167 (1993-03-01), None
patent: WO 93/08289 (1993-04-01), None
patent: WO 93/10450 (1993-05-01), None
patent: WO 93/15406 (1993-08-01), None
patent: WO 93/19096 (1993-09-01), None
patent: WO 93/19734 (1993-10-01), None
patent: WO 94/12618 (1994-06-01), None
patent: WO 94/21689 (1994-09-01), None
patent: WO 95/13830 (1995-05-01), None
patent: WO 95/34635 (1995-12-01), None
patent: WO 96/01648 (1996-01-01), None
patent: WO 96/32149 (1996-10-01), None
patent: WO 97/06783 (1997-02-01), None
patent: WO 97/16556 (1997-05-01), None
patent: WO 97/35562 (1997-10-01), None
patent: WO 98/04902 (1998-02-01), None
patent: WO 98/31346 (1998-07-01), None
patent: WO 00/12726 (2000-03-01), None
patent: WO 00/65521 (2000-11-01), None
patent: WO 00/65521 (2000-11-01), None
Yamada S. Structural Studies on the Bacterial Lyase Resistant Tetrasaccharides Derived from the Antithrombin III Binding Site of Porcine Intestinal Heparin. J of Biological Chemistry 268(7)4780-4787, 1992.
Liu, J. Strategy for the Sequence Analysis of Heparin. Glycobiology 5(8)765-774, 1995.
Yamada S. Structural Studies on the Bacterial Lyase Resistant Tetrasaccharides . . . J of Biological Chemistry. 268(7)4780-4787, 1992.
Gioldassi X. Determination of Phosphorylated and Sulfated Linkage Region Oligosaccharides . . . J Liquid Chromatography & Related Technology 22(13) 1997-2007, 1999.
Yamada, S. et al.,Structural Studies on the Bacterial Lyase-Resistant Tetrasaccharides Derived From the Antithrombin III-Binding Site of Porcine Intestinal Heparin,J. Biol. Chem. 268(7):4780 (1993).
Kishibe et al.,Structural requirements of heparan sulfate for the binding to the tumor-derived adhesion factor/angiomodulin that induces cord-like structures to the EVC-304 human carcinoma cells,J. Biol. Chem. 275(20):15321-15329 (2000).
Keiser, N. et al., “Direct isolation and sequencing of specific protein-binding glycosaminoglycans”,Nature Medicine,Jan. 2001, pp. 123-128, vol. 7, No. 1.
Pojasek, K. et al., “Recombinant Expression, Purification, and Kinetic Characterization of Chondroitinase AC and Chondroitinase B fromFlavobacterium heparinum”, Biochemical and Biophysical Communications,2001, pp. 343-361, vol. 286, No. 2, Academic Press.
Sasisekharan, R. et al., “Heparin and heparan sulfate: biosynthesis, structure and function”,Curr. Opin. Chem. Biol.,Dec. 2000, pp. 626-631, vol. 4, No. 6.
Zhang, L. et al., “6-O-Sulfotransferase-I Represents a Critical Enzyme in the Anticoagulant Heparan Sulfate Biosynthetic Pathway”,The Journal of Biological Chemistry,Nov. 9, 2001, pp. 42311-42321, vol. 276, No. 45, The American Society of Biochemistry and Molecular Biology, Inc. USA.
McLean; M.W., et al. “Enzymic Removal of 2-O-Sulphate-Δ4, 5-Glycuronic Acid Residues from Heparin Oligosaccharides”,Proceeding of the 7thInternational Symposium of Glycoconjugates,pp. 68-69, 1983.
Alderman, C.P. et al., “Continuous Subcutaneous Heparin Infusion for Treatment of Trousseau's Syndrome”,The Annals of Pharmacotherapy,Jul./Aug. 1995, pp. 710-713, vol. 29.
Bernstein, H. et al., “Immobilized Heparin Lyase System for Blood Deheparinization”,Methods in Enzymology,1988, pp. 515-529, vol. 137, Academic Press, Inc.
Cardin, A.D. et al., “Molecular Modeling of Protein-Glycosaminoglycan Interactions”,Arteriosclerosis,Jan./Feb. 1989, pp. 21-32, vol. 9, No. 1.
Carlson, T.H. et al., “Behavior of Antithrombin III isoforms on Immobilized Heparins—Evidence that the isoforms bind to different numbers of low-affinity Heparin sites”,The Journal of Biological Chemistry,Feb. 15, 1988, pp. 2187-2194, vol. 263, No. 5, The American Society for Biochemistry and Molecular Biology, Inc. USA.
Comfort, A.R. et al., “Immobilized Enzyme Cellulose Hollow Fibers: III. Physical Properties and In Vitro Biocompatibility”,Biotechnology and Bioengineering,1989, pp. 1383-1390, vol. 34, John Wiley & Sons, Inc.
Enriquez-Harris, P. et al., “Growth factors and the extracellular matrix”,Meeting Report, Trends in Cell Biology,1994, 2 Pages.
Ernst, S. et al., “Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I”,Proc. Natl. Acad. Sci. USA,Apr. 1998, pp. 4182-4187, vol. 95.
Feingold, D.S. et al., “Conformational aspects of the reaction mechanisms of polysaccharide lyases and epimerases”,

Affiliated with

Also associated with

Rating

Methods and products related to the analysis of polysaccarides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and products related to the analysis of polysaccarides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and products related to the analysis of polysaccarides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3615857